Reolysin: Phase II started

Oncolytics said the Gynecologic Oncology Group (GOG) began an open-label Phase II trial to compare IV Reolysin given on days 1-5 of a 28-day cycle in combination with weekly paclitaxel vs. paclitaxel ...